| 000 | 01853 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250515095529.0 | ||
| 264 | 0 | _c20081028 | |
| 008 | 200810s 0 0 eng d | ||
| 022 | _a1468-2060 | ||
| 024 | 7 |
_a10.1136/ard.2007.079921 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDenton, C P | |
| 245 | 0 | 0 |
_aLong-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases. _h[electronic resource] |
| 260 |
_bAnnals of the rheumatic diseases _cSep 2008 |
||
| 300 |
_a1222-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xadverse effects |
| 650 | 0 | 4 | _aBosentan |
| 650 | 0 | 4 |
_aConnective Tissue Diseases _xcomplications |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aEpidemiologic Methods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucocorticoids _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension, Pulmonary _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aSulfonamides _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aPope, J E | |
| 700 | 1 | _aPeter, H-H | |
| 700 | 1 | _aGabrielli, A | |
| 700 | 1 | _aBoonstra, A | |
| 700 | 1 | _avan den Hoogen, F H J | |
| 700 | 1 | _aRiemekasten, G | |
| 700 | 1 | _aDe Vita, S | |
| 700 | 1 | _aMorganti, A | |
| 700 | 1 | _aDölberg, M | |
| 700 | 1 | _aBerkani, O | |
| 700 | 1 | _aGuillevin, L | |
| 773 | 0 |
_tAnnals of the rheumatic diseases _gvol. 67 _gno. 9 _gp. 1222-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/ard.2007.079921 _zAvailable from publisher's website |
| 999 |
_c17569858 _d17569858 |
||